Biznes i finanse

SOPHARMA AD (67/2022) Sales revenues for July 2022

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

„Sopharma” AD (the Company) notifies that for July 2022 the Company recorded an increase in sales of 146% compared to the same month of the previous year, incl. 96% increase in domestic sales and 206% increase in export sales.

For the seven months since the beginning of the year the revenues from sales of products increase by 46%, incl. 42% increase of sales for the domestic market and 49% increase in export sales.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz


Treść pochodzi z serwisu: pap-mediaroom.pl

Wykorzystujemy pliki cookies.
Polityka Prywatności
Więcej
ROZUMIEM